aluates Reports

$ 0.0

Automative

Global Drug Modeling Softwares Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-19T5897

Global Drug Modeling Softwares Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Drug Modeling Softwares Market Research Report 2025

Code: QYRE-Auto-19T5897

Report

July 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

JSR Corporation(Crown Bioscience)

Chemical Computing Group ULC

Nimbus Therapeutics

Schrodinger Llc

Genedata Ag

Biognos Ab

Compugen

Dassault Systemes

Acellera

Instem(Leadscope)

Drug Modeling Softwares Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drug Modeling Softwares Market

The global market for Drug Modeling Softwares was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Modeling Softwares, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Modeling Softwares.

The Drug Modeling Softwares market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Modeling Softwares market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Modeling Softwares companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Modeling Softwares Market Report

Report Metric	Details
Report Name	Drug Modeling Softwares Market
CAGR	5%
Segment by Type	Database Software Others
Segment by Application	Drug Discovery and Development Computational Physiological Medicine Disease Modelling Medical Imaging Predictive Analysis of Drug Targets Simulation Software Cellular Simulation Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, Schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes, Acellera, Instem(Leadscope)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Modeling Softwares company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Modeling Softwares Market report?

Ans: The main players in the Drug Modeling Softwares Market are JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, Schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes, Acellera, Instem(Leadscope)

What are the Application segmentation covered in the Drug Modeling Softwares Market report?

Ans: The Applications covered in the Drug Modeling Softwares Market report are Drug Discovery and Development, Computational Physiological Medicine, Disease Modelling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation, Others

What are the Type segmentation covered in the Drug Modeling Softwares Market report?

Ans: The Types covered in the Drug Modeling Softwares Market report are Database, Software, Others

Recommended Reports

Pharmaceutical Drug Markets

Pharma Software & Services

Pharmaceutical Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Modeling Softwares Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Database

1.2.3 Software

1.2.4 Others

1.3 Market by Application

1.3.1 Global Drug Modeling Softwares Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Drug Discovery and Development

1.3.3 Computational Physiological Medicine

1.3.4 Disease Modelling

1.3.5 Medical Imaging

1.3.6 Predictive Analysis of Drug Targets

1.3.7 Simulation Software

1.3.8 Cellular Simulation

1.3.9 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Modeling Softwares Market Perspective (2020-2031)

2.2 Global Drug Modeling Softwares Growth Trends by Region

2.2.1 Global Drug Modeling Softwares Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drug Modeling Softwares Historic Market Size by Region (2020-2025)

2.2.3 Drug Modeling Softwares Forecasted Market Size by Region (2026-2031)

2.3 Drug Modeling Softwares Market Dynamics

2.3.1 Drug Modeling Softwares Industry Trends

2.3.2 Drug Modeling Softwares Market Drivers

2.3.3 Drug Modeling Softwares Market Challenges

2.3.4 Drug Modeling Softwares Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Modeling Softwares Players by Revenue

3.1.1 Global Top Drug Modeling Softwares Players by Revenue (2020-2025)

3.1.2 Global Drug Modeling Softwares Revenue Market Share by Players (2020-2025)

3.2 Global Drug Modeling Softwares Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drug Modeling Softwares Revenue

3.4 Global Drug Modeling Softwares Market Concentration Ratio

3.4.1 Global Drug Modeling Softwares Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Modeling Softwares Revenue in 2024

3.5 Global Key Players of Drug Modeling Softwares Head office and Area Served

3.6 Global Key Players of Drug Modeling Softwares, Product and Application

3.7 Global Key Players of Drug Modeling Softwares, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Modeling Softwares Breakdown Data by Type

4.1 Global Drug Modeling Softwares Historic Market Size by Type (2020-2025)

4.2 Global Drug Modeling Softwares Forecasted Market Size by Type (2026-2031)

5 Drug Modeling Softwares Breakdown Data by Application

5.1 Global Drug Modeling Softwares Historic Market Size by Application (2020-2025)

5.2 Global Drug Modeling Softwares Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drug Modeling Softwares Market Size (2020-2031)

6.2 North America Drug Modeling Softwares Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drug Modeling Softwares Market Size by Country (2020-2025)

6.4 North America Drug Modeling Softwares Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Modeling Softwares Market Size (2020-2031)

7.2 Europe Drug Modeling Softwares Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drug Modeling Softwares Market Size by Country (2020-2025)

7.4 Europe Drug Modeling Softwares Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Modeling Softwares Market Size (2020-2031)

8.2 Asia-Pacific Drug Modeling Softwares Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drug Modeling Softwares Market Size by Region (2020-2025)

8.4 Asia-Pacific Drug Modeling Softwares Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Modeling Softwares Market Size (2020-2031)

9.2 Latin America Drug Modeling Softwares Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drug Modeling Softwares Market Size by Country (2020-2025)

9.4 Latin America Drug Modeling Softwares Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Modeling Softwares Market Size (2020-2031)

10.2 Middle East & Africa Drug Modeling Softwares Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drug Modeling Softwares Market Size by Country (2020-2025)

10.4 Middle East & Africa Drug Modeling Softwares Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 JSR Corporation(Crown Bioscience)

11.1.1 JSR Corporation(Crown Bioscience) Company Details

11.1.2 JSR Corporation(Crown Bioscience) Business Overview

11.1.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Introduction

11.1.4 JSR Corporation(Crown Bioscience) Revenue in Drug Modeling Softwares Business (2020-2025)

11.1.5 JSR Corporation(Crown Bioscience) Recent Development

11.2 Chemical Computing Group ULC

11.2.1 Chemical Computing Group ULC Company Details

11.2.2 Chemical Computing Group ULC Business Overview

11.2.3 Chemical Computing Group ULC Drug Modeling Softwares Introduction

11.2.4 Chemical Computing Group ULC Revenue in Drug Modeling Softwares Business (2020-2025)

11.2.5 Chemical Computing Group ULC Recent Development

11.3 Nimbus Therapeutics

11.3.1 Nimbus Therapeutics Company Details

11.3.2 Nimbus Therapeutics Business Overview

11.3.3 Nimbus Therapeutics Drug Modeling Softwares Introduction

11.3.4 Nimbus Therapeutics Revenue in Drug Modeling Softwares Business (2020-2025)

11.3.5 Nimbus Therapeutics Recent Development

11.4 Schrodinger, Inc

11.4.1 Schrodinger, Inc Company Details

11.4.2 Schrodinger, Inc Business Overview

11.4.3 Schrodinger, Inc Drug Modeling Softwares Introduction

11.4.4 Schrodinger, Inc Revenue in Drug Modeling Softwares Business (2020-2025)

11.4.5 Schrodinger, Inc Recent Development

11.5 Genedata AG

11.5.1 Genedata AG Company Details

11.5.2 Genedata AG Business Overview

11.5.3 Genedata AG Drug Modeling Softwares Introduction

11.5.4 Genedata AG Revenue in Drug Modeling Softwares Business (2020-2025)

11.5.5 Genedata AG Recent Development

11.6 Biognos AB

11.6.1 Biognos AB Company Details

11.6.2 Biognos AB Business Overview

11.6.3 Biognos AB Drug Modeling Softwares Introduction

11.6.4 Biognos AB Revenue in Drug Modeling Softwares Business (2020-2025)

11.6.5 Biognos AB Recent Development

11.7 Compugen Ltd

11.7.1 Compugen Ltd Company Details

11.7.2 Compugen Ltd Business Overview

11.7.3 Compugen Ltd Drug Modeling Softwares Introduction

11.7.4 Compugen Ltd Revenue in Drug Modeling Softwares Business (2020-2025)

11.7.5 Compugen Ltd Recent Development

11.8 Dassault Systemes

11.8.1 Dassault Systemes Company Details

11.8.2 Dassault Systemes Business Overview

11.8.3 Dassault Systemes Drug Modeling Softwares Introduction

11.8.4 Dassault Systemes Revenue in Drug Modeling Softwares Business (2020-2025)

11.8.5 Dassault Systemes Recent Development

11.9 Acellera

11.9.1 Acellera Company Details

11.9.2 Acellera Business Overview

11.9.3 Acellera Drug Modeling Softwares Introduction

11.9.4 Acellera Revenue in Drug Modeling Softwares Business (2020-2025)

11.9.5 Acellera Recent Development

11.10 Instem(Leadscope)

11.10.1 Instem(Leadscope) Company Details

11.10.2 Instem(Leadscope) Business Overview

11.10.3 Instem(Leadscope) Drug Modeling Softwares Introduction

11.10.4 Instem(Leadscope) Revenue in Drug Modeling Softwares Business (2020-2025)

11.10.5 Instem(Leadscope) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

JSR Corporation(Crown Bioscience)

Chemical Computing Group ULC

Nimbus Therapeutics

Schrodinger Llc

Genedata Ag

Biognos Ab

Compugen

Dassault Systemes

Acellera

Instem(Leadscope)

List of Tables

Table 1. Global Drug Modeling Softwares Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Database

Table 3. Key Players of Software

Table 4. Key Players of Others

Table 5. Global Drug Modeling Softwares Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Drug Modeling Softwares Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Drug Modeling Softwares Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Drug Modeling Softwares Market Share by Region (2020-2025)

Table 9. Global Drug Modeling Softwares Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Drug Modeling Softwares Market Share by Region (2026-2031)

Table 11. Drug Modeling Softwares Market Trends

Table 12. Drug Modeling Softwares Market Drivers

Table 13. Drug Modeling Softwares Market Challenges

Table 14. Drug Modeling Softwares Market Restraints

Table 15. Global Drug Modeling Softwares Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Drug Modeling Softwares Market Share by Players (2020-2025)

Table 17. Global Top Drug Modeling Softwares Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2024)

Table 18. Ranking of Global Top Drug Modeling Softwares Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Drug Modeling Softwares Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Drug Modeling Softwares, Headquarters and Area Served

Table 21. Global Key Players of Drug Modeling Softwares, Product and Application

Table 22. Global Key Players of Drug Modeling Softwares, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Drug Modeling Softwares Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Drug Modeling Softwares Revenue Market Share by Type (2020-2025)

Table 26. Global Drug Modeling Softwares Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Drug Modeling Softwares Revenue Market Share by Type (2026-2031)

Table 28. Global Drug Modeling Softwares Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Drug Modeling Softwares Revenue Market Share by Application (2020-2025)

Table 30. Global Drug Modeling Softwares Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Drug Modeling Softwares Revenue Market Share by Application (2026-2031)

Table 32. North America Drug Modeling Softwares Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Drug Modeling Softwares Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Drug Modeling Softwares Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Drug Modeling Softwares Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Drug Modeling Softwares Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Drug Modeling Softwares Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Drug Modeling Softwares Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Drug Modeling Softwares Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Drug Modeling Softwares Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Drug Modeling Softwares Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Drug Modeling Softwares Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Drug Modeling Softwares Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Drug Modeling Softwares Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Drug Modeling Softwares Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Drug Modeling Softwares Market Size by Country (2026-2031) & (US$ Million)

Table 47. JSR Corporation(Crown Bioscience) Company Details

Table 48. JSR Corporation(Crown Bioscience) Business Overview

Table 49. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Product

Table 50. JSR Corporation(Crown Bioscience) Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 51. JSR Corporation(Crown Bioscience) Recent Development

Table 52. Chemical Computing Group ULC Company Details

Table 53. Chemical Computing Group ULC Business Overview

Table 54. Chemical Computing Group ULC Drug Modeling Softwares Product

Table 55. Chemical Computing Group ULC Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 56. Chemical Computing Group ULC Recent Development

Table 57. Nimbus Therapeutics Company Details

Table 58. Nimbus Therapeutics Business Overview

Table 59. Nimbus Therapeutics Drug Modeling Softwares Product

Table 60. Nimbus Therapeutics Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 61. Nimbus Therapeutics Recent Development

Table 62. Schrodinger, Inc Company Details

Table 63. Schrodinger, Inc Business Overview

Table 64. Schrodinger, Inc Drug Modeling Softwares Product

Table 65. Schrodinger, Inc Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 66. Schrodinger, Inc Recent Development

Table 67. Genedata AG Company Details

Table 68. Genedata AG Business Overview

Table 69. Genedata AG Drug Modeling Softwares Product

Table 70. Genedata AG Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 71. Genedata AG Recent Development

Table 72. Biognos AB Company Details

Table 73. Biognos AB Business Overview

Table 74. Biognos AB Drug Modeling Softwares Product

Table 75. Biognos AB Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 76. Biognos AB Recent Development

Table 77. Compugen Ltd Company Details

Table 78. Compugen Ltd Business Overview

Table 79. Compugen Ltd Drug Modeling Softwares Product

Table 80. Compugen Ltd Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 81. Compugen Ltd Recent Development

Table 82. Dassault Systemes Company Details

Table 83. Dassault Systemes Business Overview

Table 84. Dassault Systemes Drug Modeling Softwares Product

Table 85. Dassault Systemes Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 86. Dassault Systemes Recent Development

Table 87. Acellera Company Details

Table 88. Acellera Business Overview

Table 89. Acellera Drug Modeling Softwares Product

Table 90. Acellera Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 91. Acellera Recent Development

Table 92. Instem(Leadscope) Company Details

Table 93. Instem(Leadscope) Business Overview

Table 94. Instem(Leadscope) Drug Modeling Softwares Product

Table 95. Instem(Leadscope) Revenue in Drug Modeling Softwares Business (2020-2025) & (US$ Million)

Table 96. Instem(Leadscope) Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Drug Modeling Softwares Picture

Figure 2. Global Drug Modeling Softwares Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drug Modeling Softwares Market Share by Type: 2024 VS 2031

Figure 4. Database Features

Figure 5. Software Features

Figure 6. Others Features

Figure 7. Global Drug Modeling Softwares Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Drug Modeling Softwares Market Share by Application: 2024 VS 2031

Figure 9. Drug Discovery and Development Case Studies

Figure 10. Computational Physiological Medicine Case Studies

Figure 11. Disease Modelling Case Studies

Figure 12. Medical Imaging Case Studies

Figure 13. Predictive Analysis of Drug Targets Case Studies

Figure 14. Simulation Software Case Studies

Figure 15. Cellular Simulation Case Studies

Figure 16. Others Case Studies

Figure 17. Drug Modeling Softwares Report Years Considered

Figure 18. Global Drug Modeling Softwares Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Drug Modeling Softwares Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Drug Modeling Softwares Market Share by Region: 2024 VS 2031

Figure 21. Global Drug Modeling Softwares Market Share by Players in 2024

Figure 22. Global Top Drug Modeling Softwares Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Drug Modeling Softwares Revenue in 2024

Figure 24. North America Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Drug Modeling Softwares Market Share by Country (2020-2031)

Figure 26. United States Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Drug Modeling Softwares Market Share by Country (2020-2031)

Figure 30. Germany Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Drug Modeling Softwares Market Share by Region (2020-2031)

Figure 38. China Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Drug Modeling Softwares Market Share by Country (2020-2031)

Figure 46. Mexico Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Drug Modeling Softwares Market Share by Country (2020-2031)

Figure 50. Turkey Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Drug Modeling Softwares Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. JSR Corporation(Crown Bioscience) Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 54. Chemical Computing Group ULC Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 55. Nimbus Therapeutics Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 56. Schrodinger, Inc Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 57. Genedata AG Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 58. Biognos AB Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 59. Compugen Ltd Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 60. Dassault Systemes Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 61. Acellera Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 62. Instem(Leadscope) Revenue Growth Rate in Drug Modeling Softwares Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Computational Medicine and Drug Designing Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Aided Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

New Drug Modeling Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Discovery Software Market Insights Forecast to 2030

Global Pharmaceutical Industry software Market Insights Forecast to 2030

Global Pharmacokinetics Software Market Research Report 2024

3D Structural Modeling Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Modelling Software Market Research Report 2024

Computer Aided Drug Discovery CADD Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cloud Based Molecular Modelling Software Market Research Report 2024

Global Pharma Forecasting Software Market Research Report 2024

Pharmaceutical Quality Management Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Treatment Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Computer assisted Drug Design Platform Market Research Report 2024

Drug Designing Tools Market

Global Pharmaceutical Manufacturing Software Market Insights Forecast to 2030

Building Energy Modeling Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Treatment Planning Software Market Research Report 2025

Global Small Molecule Drug Design Software Market Research Report 2024

RELATED REPORTS

Global BYOD Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11T6229

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Translation Management Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36Z5964

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Archiving Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11S6221

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Point of Sale Automation System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11J6299

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions